495 filings
Page 9 of 25
SC 13D/A
APVO
Aptevo Therapeutics Inc
21 Jun 21
Aptevo Therapeutics / TANG CAPITAL PARTNERS ownership change
9:00am
4
APVO
Aptevo Therapeutics Inc
2 Jun 21
Aptevo Therapeutics / John Niederhuber ownership change
7:35pm
4
Kunz Barbara Lopez
2 Jun 21
Aptevo Therapeutics / Barbara Lopez Kunz ownership change
7:34pm
4
APVO
Aptevo Therapeutics Inc
2 Jun 21
Aptevo Therapeutics / Zsolt Harsanyi ownership change
7:34pm
4
Grady Grant III
2 Jun 21
Aptevo Therapeutics / Grady Grant III ownership change
7:33pm
4
APVO
Aptevo Therapeutics Inc
2 Jun 21
Aptevo Therapeutics / Fuad El-Hibri ownership change
7:33pm
4
APVO
Aptevo Therapeutics Inc
2 Jun 21
Aptevo Therapeutics / Daniel Abdun-Nabi ownership change
7:32pm
4
SoYoung Kwon
2 Jun 21
Aptevo Therapeutics / SoYoung Kwon ownership change
7:31pm
3
SoYoung Kwon
2 Jun 21
Aptevo Therapeutics / SoYoung Kwon ownership change
7:30pm
8-K
APVO
Aptevo Therapeutics Inc
27 May 21
Aptevo Therapeutics Announces Expansion Phase of Lead Anti-leukemia Drug APVO436 In Adult Patients with Acute Myeloid Leukemia
9:02am
8-K
APVO
Aptevo Therapeutics Inc
26 May 21
Regulation FD Disclosure
9:00am
DEFC14A
APVO
Aptevo Therapeutics Inc
11 May 21
Proxy in contested solicitation
8:55am
10-Q
2021 Q1
APVO
Aptevo Therapeutics Inc
Quarterly report
11 May 21
8:51am
8-K
APVO
Aptevo Therapeutics Inc
11 May 21
Aptevo Therapeutics Reports First Quarter 2021 Financial Results
8:46am
CORRESP
APVO
Aptevo Therapeutics Inc
5 May 21
Correspondence with SEC
12:00am
UPLOAD
APVO
Aptevo Therapeutics Inc
4 May 21
Letter from SEC
12:00am
PREC14A
APVO
Aptevo Therapeutics Inc
28 Apr 21
Preliminary proxy with contested solicitation
4:20pm
10-K/A
2020 FY
APVO
Aptevo Therapeutics Inc
Annual report (amended)
28 Apr 21
4:16pm
DEFA14A
APVO
Aptevo Therapeutics Inc
31 Mar 21
Additional proxy soliciting materials
8:04am
8-K
APVO
Aptevo Therapeutics Inc
31 Mar 21
Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update
8:04am